Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 783-785

  Ikezoe, T ^a   Togitani, K ^a   Komatsu, N ^a   Isaka, M ^a   Yokoyama, A ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III CONCENTRATE; BILIRUBIN; CYCLOSPORIN; CYCLOSPORIN A; DEFIBROTIDE; DOXORUBICIN; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT THROMBOMODULIN; TACROLIMUS; VINCRISTINE;

ABDOMINAL TENDERNESS; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CANCER REGRESSION; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FIBRINOGEN METABOLISM; GENERAL CONDITION DETERIORATION; GRAFT VERSUS HOST REACTION; HEPATOMEGALY; HLA MATCHING; HUMAN; LETTER; LIVER VENOOCCLUSIVE DISEASE; MULTIPLE CYCLE TREATMENT; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; T CELL LEUKEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN; WHOLE BODY RADIATION;

ADULT; ANTITHROMBIN III; BIOLOGICAL FACTORS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBOMODULIN;

EID: 77950624556     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.217     Document Type: Letter

References (10)

1. Kumar S, DeLeve LD, Kamath PS, Tefferi A. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589-598. (Pubitemid 36529900)
2. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
3. DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 2003; 284: G1045-G1052. (Pubitemid 36597348)
4. Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica 2006; 91: 795-800. (Pubitemid 44014546)
5. Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 2008; 41: 229-237. (Pubitemid 351260376)
6. Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in patients after stem cell transplantation with severe venoocclusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337-4343.
7. Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thoromb Haemost 1999; 82: 718-721.
8. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, doubleblind clinical trial. J Thromb Haemost 2007; 5: 31-41. (Pubitemid 44921064)
9. Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977-1983. (Pubitemid 35001226)
10. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005; 115: 1267-1274. (Pubitemid 40629045)